FDA Sees No New Safety Signals for Silicone Breast Implants
Posted on 22. Jun, 2011 by Dr. Ellis in News and Updates
(MedPage Today) — The FDA’s preliminary review of postmarketing safety studies on silicone breast implants, released Wednesday, found no evidence that the products increase the risk of breast cancer, reproductive abnormalities, or other problems.
Read Full Article…
Rx for Secondary Prevention May Not Save Money
Posted on 21. Apr, 2011 by Dr. Ellis in News and Updates
(MedPage Today) — There is a lack of evidence that drugs such as statins and anti-hypertensives used to reduce risk of cardiovascular events are cost-effective treatments, according to a study from Finland published online in the BMJ.
Read Full Article…
Panel Endorses Weight-Loss Drug
Posted on 07. Dec, 2010 by Dr. Ellis in News and Updates
(MedPage Today) — SILVER SPRING, Md. — An FDA advisory committee has voted 13-7 that the modest weight-loss benefits of an investigational combination of naltrexone and bupropion (Contrave) outweigh the drug’s blood pressure risk.
Read Full Article…
Panel to Vote on Thyroid Cancer Drug
Posted on 30. Nov, 2010 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — The investigational cancer drug vandetanib (Zactima), which is under FDA review for approval to treat a rare, inoperable thyroid cancer, carries a “substantial” toxicity risk, FDA reviewers said.
Read Full Article…
Baucus Calls for Repeal of 1099 Provision in ACA
Posted on 12. Nov, 2010 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — Sen. Max Baucus (D-Mont.) on Friday said he would introduce a bill to repeal an unpopular provision in the healthcare reform law that requires employers to fill out a 1099 tax form every time they spend $600 on goods and services.
Read Full Article…
Possibly Related Blogs
FDA Asks for Tougher Warnings on GnRH Agonists
Posted on 20. Oct, 2010 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — The FDA has asked manufacturers of gonadotropin-releasing hormone (GnRH) agonists — a class of drugs used primarily to treat prostate cancer — to add new warnings about the potential risk for heart disease and diabetes.
Read Full Article…
Possibly Related Blogs
Improve Fast-Track Approval Process for Some Medical Devices: FDA Staff
Posted on 03. Aug, 2010 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — The FDA has issued two reports aimed at improving the controversial fast-track approval process used by the agency’s Center for Devices and Radiological Health (CDRH) for low- to mid-risk medical devices.
Read Full Article…
Possibly Related Blogs
VA Report Calls for More Study of Gulf War Illness
Posted on 03. Apr, 2010 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — A new report by a Department of Veterans Affairs (VA) task force lays out the department’s plans to better address veterans’ medical needs and “reenergize” the VA’s research into the causes of nervous system illnesses affecting many veterans of the 1990-1991 Gulf War conflict.
Read Full Article…
Possibly Related Blogs
Week 38: Healthcare Reform Becomes Law
Posted on 27. Mar, 2010 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — After a yearlong, often acrimonious, battle, final passage of healthcare reform was clouded by arcane congressional procedure.
Read Full Article…
